Sheffield Clinical Genetics Service, Sheffield Children's NHS Foundation Trust, Sheffield, UK.
Clinical Genetics, Birmingham Women's and Children's NHS Foundation Trust, Birmingham, UK.
Am J Med Genet A. 2020 Apr;182(4):713-720. doi: 10.1002/ajmg.a.61483. Epub 2020 Jan 11.
Developmental and Epileptic encephalopathies (DEE) describe heterogeneous epilepsy syndromes, characterized by early-onset, refractory seizures and developmental delay (DD). Several DEE associated genes have been reported. With increased access to whole exome sequencing (WES), new candidate genes are being identified although there are fewer large cohort papers describing the clinical phenotype in such patients. We describe 6 unreported individuals and provide updated information on an additional previously reported individual with heterozygous de novo missense variants in YWHAG. We describe a syndromal phenotype, report 5 novel, and a recurrent p.Arg132Cys YWHAG variant and compare developmental trajectory and treatment strategies in this cohort. We provide further evidence of causality in YWHAG variants. WES was performed in five patients via Deciphering Developmental Disorders Study and the remaining two were identified via Genematcher and AnnEX databases. De novo variants identified from exome data were validated using Sanger sequencing. Seven out of seven patients in the cohort have de novo, heterozygous missense variants in YWHAG including 2/7 patients with a recurrent c.394C > T, p.Arg132Cys variant; 1/7 has a second, pathogenic variant in STAG1. Characteristic features included: early-onset seizures, predominantly generalized tonic-clonic and absence type (7/7) with good response to standard anti-epileptic medications; moderate DD; Intellectual Disability (ID) (5/7) and Autism Spectrum Disorder (3/7). De novo YWHAG missense variants cause EE, characterized by early-onset epilepsy, ID and DD, supporting the hypothesis that YWHAG loss-of-function causes a neurological phenotype. Although the exact mechanism of disease resulting from alterations in YWHAG is not fully known, it is possible that haploinsufficiency of YWHAG in developing cerebral cortex may lead to abnormal neuronal migration resulting in DEE.
发育性和癫痫性脑病 (DEE) 描述了具有异质性的癫痫综合征,其特征为早发性、难治性癫痫发作和发育迟缓 (DD)。已经报道了几种与 DEE 相关的基因。随着全外显子组测序 (WES) 的广泛应用,尽管描述此类患者临床表型的大型队列论文较少,但新的候选基因正在被发现。我们描述了 6 例未报道的个体,并提供了先前报道的具有杂合性新生错义变异的 YWHAG 个体的更新信息。我们描述了一种综合征表型,报告了 5 种新的和一种复发的 p.Arg132Cys YWHAG 变异,并比较了该队列的发育轨迹和治疗策略。我们为 YWHAG 变异提供了进一步的因果关系证据。通过解析发育障碍研究对五名患者进行了 WES,其余两名通过 Genematcher 和 AnnEX 数据库进行了鉴定。使用 Sanger 测序验证从外显子数据中鉴定的新生变异。该队列的 7 名患者中有 7 名存在 YWHAG 的新生杂合错义变异,包括 2/7 名患者存在复发的 c.394C > T,p.Arg132Cys 变异;1/7 名患者存在 STAG1 的第二个致病性变异。特征性表现包括:早发性癫痫发作,主要为全面强直阵挛性和失神性(7/7),对标准抗癫痫药物反应良好;中度 DD;智力障碍 (ID)(5/7)和自闭症谱系障碍 (3/7)。新生 YWHAG 错义变异引起 EE,其特征为早发性癫痫、ID 和 DD,支持 YWHAG 功能丧失导致神经表型的假说。虽然由于 YWHAG 改变导致疾病的确切机制尚未完全清楚,但 YWHAG 在发育中的大脑皮层中的杂合性缺失可能导致异常的神经元迁移,从而导致 DEE。